Genomic testing for bleeding disorders (GT4BD): protocol for a randomised controlled trial evaluating the introduction of whole genome sequencing early in the diagnostic pathway for patients with inherited bleeding disorders as compared with standard
Genomic testing for bleeding disorders (GT4BD): protocol for a randomised controlled trial evaluating the introduction of whole genome sequencing early in the diagnostic pathway for patients with inherited bleeding disorders as compared with standard
Megan Chaigneau, David Lillicrap, Alyson L Mahar, Paula James et al.
Citations
1 citations
Journal
BMJ Open
Topics
Hemophilia Treatment and Research
Field-Weighted Citation Impact (FWCI)
1.77
article
Genomic testing for bleeding disorders (GT4BD): protocol for a randomised controlled trial evaluating the introduction of whole genome sequencing early in the diagnostic pathway for patients with inherited bleeding disorders as compared with standard
Megan Chaigneau, David Lillicrap, Alyson L Mahar, Paula James, Roy Khalifé, Kevin E. Thorpe, Jennifer Leung, Laura Wheaton, Michael J. Conboy, Julie Grabell, Andrew D. Paterson, Mackenzie Bowman, Andrea Guerin, Michelle Sholzberg, David Good, A. L. Johnson, Jeannie Callum, Rachelle Dinchong
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(4)
Institutions
St. Michael's Hospital (CA), University of Ottawa (CA), University of Toronto (CA), Queen's University (CA), Ottawa Hospital (CA), Hospital for Sick Children (CA), Public Health Ontario (CA), Kingston Health Sciences Centre (CA)